Gemcitabine and cisplatin in advanced non small cell lung cancer (NSCLC)

被引：0
|
作者：
Garcia-Gomez, R [1 ]
Lopez-Criado, P [1 ]
Guevara, S [1 ]
Lahoz, C [1 ]
Chaib, C [1 ]
Gonzalez, C [1 ]
Santiago, J [1 ]
De Alvaro, J [1 ]
Carrion, R [1 ]
Perez-Manga, G [1 ]
机构：
[1] Hosp Gen Gregorio Maranon, So Oncol Med, Madrid, Spain
来源：
ANNALS OF ONCOLOGY | 1998年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
450
引用
收藏
页码：93 / 94
页数：2
相关论文
共 50 条
  • [31] Phase II trial of gemcitabine and cisplatin as first-line treatment of advanced non-small cell lung cancer (NSCLC).
    Lee, NS
    Byun, JH
    Bae, SB
    Kim, CK
    Lee, KT
    Park, SK
    Park, KK
    Won, JH
    Hong, DS
    Park, HS
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 701S - 701S
  • [32] A phase II study of a modified cisplatin and Gemcitabine regimen in advanced non-small cell lung cancer (NSCLC): An ongoing study
    Gonzalez-Martin, A
    Garcia-Lopez, JL
    Crespo, C
    Lastra, E
    Pedraza, M
    Cerrato, L
    Rios, A
    Moyano, AJ
    Garrido, P
    ANNALS OF ONCOLOGY, 1998, 9 : 98 - 98
  • [33] Gemcitabine-cisplatin combination in non-small cell lung cancer (NSCLC). A phase II study
    Crino, L
    Seagliotti, G
    Marangolo, M
    Figoli, F
    Clerici, M
    DeMarinis, F
    Salvati, F
    Cruciani, G
    Dogliotti, L
    Cocconi, G
    Paccagnella, A
    Adamo, V
    Incoronato, P
    Scarcella, L
    Mosconi, AM
    Tonato, M
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1064 - 1064
  • [34] Gemcitabine combined with cisplatin in non-small cell lung cancer (NSCLC): A phase I/II study
    Steward, WP
    Dunlop, DJ
    Cameron, C
    Talbot, DC
    Kleisbauer, JL
    Thomas, P
    Guerin, JC
    Perol, M
    Sanson, C
    Dabouis, G
    Lacroix, H
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1081 - 1081
  • [35] Gemcitabine plus cisplatin in patients with state IIIB/IV non-small cell lung cancer (NSCLC)
    Teixeira, Encarnacao
    Goncalves, Ines
    Mayor, Renato Sotto
    Melo, Ricardo
    Lopes, Carlos
    Pinto, Ana
    ANNALS OF ONCOLOGY, 2004, 15 : 194 - 194
  • [36] Phase I trial of gemcitabine (GEM) and cisplatin (CP) for non-small cell lung cancer (NSCLC)
    Shepherd, F
    Cormier, Y
    Burges, R
    Crump, M
    Strack, T
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1080 - 1080
  • [37] Vinorelbine/gemcitabine in advanced non-small cell lung cancer (NSCLC):: a phase I trial
    Krajnik, G
    Wein, W
    Greil, R
    Marhold, F
    Mohn-Staudner, A
    Kummer, F
    Malayeri, R
    Zöchbauer-Müller, S
    Huber, H
    Pirker, R
    EUROPEAN JOURNAL OF CANCER, 1998, 34 (12) : 1977 - 1980
  • [38] Weekly administration of gemcitabine plus docetaxel in advanced non-small cell lung cancer (NSCLC).
    Sun, Y
    Li, J
    Wu, Y
    Li, L
    Gu, L
    Zhang, L
    Wang, J
    Zhang, X
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 698S - 698S
  • [39] Phase II study of paclitaxel and gemcitabine in advanced non-small cell lung cancer (NSCLC).
    Lazaro, M
    Jorge, M
    Castellanos, J
    ANNALS OF ONCOLOGY, 2000, 11 : 109 - 109
  • [40] Vinorelbine/gemcitabine in advanced non-small-cell lung cancer (NSCLC): A phase I trial
    Pirker, R
    Krajnik, G
    MohnStaudner, A
    Marhold, F
    Malayeri, R
    Zochbauer, S
    Kummer, F
    Greil, R
    Huber, H
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1139 - 1139
12345